TY  - JOUR
N2  - Systemic thrombolysis for acute ischaemic stroke is the standard of care in the UK. In the absence of trial data on the safety and efficacy of this treatment in patients with end-stage renal disease, we captured the views of UK nephrologists to highlight health care policy and research objectives.
ID  - discovery1424290
KW  - Data Collection
KW  -  Humans
KW  -  Kidney Failure
KW  -  Chronic
KW  -  Nephrology
KW  -  Patient Safety
KW  -  Physician's Role
KW  -  Stroke
KW  -  Thrombolytic Therapy
TI  - Acute stroke thrombolysis in end-stage renal disease: a national survey of nephrologist opinion
AV  - public
Y1  - 2014/02//
EP  - 172
UR  - http://dx.doi.org/10.1159/000357155
SN  - 1660-2110
JF  - Nephron Clinical Practice
A1  - Power, A
A1  - Fogarty, D
A1  - Wheeler, DC
VL  - 124
SP  - 167
IS  - 3-4
N1  - This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
ER  -